Bill Title: Amends the Illinois Insurance Code. Makes changes to defined terms. Includes an annual screening (rather than surveillance tests) for ovarian cancer for insureds who are at risk for ovarian cancer using (i) CA-125 serum tumor marker testing, (ii) transvaginal ultrasound, and (iii) pelvic examination (rather than only for insureds who are at risk for ovarian cancer) in provisions requiring coverage without cost sharing. Provides that a group policy of accident and health insurance that provides coverage for hospital or medical treatment or services for illness on an expense-incurred basis and is amended, delivered, issued, or renewed on or after January 1, 2028 shall, in addition to specified coverage, provide coverage for all medically viable methods for the detection and diagnosis of ovarian cancer for insureds who are at risk for ovarian cancer. Provides that the coverage may be subject to a deductible, coinsurance, or other cost sharing. Effective January 1, 2028.
Sponsorship: Slight Partisan Bill (Republican 6-2)
Status: (Passed) 2026-07-10 - Public Act . . . . . . . . . 104-0548
[HB4203 Detail]
Bill Drafts
| Revision | Date | Format | Source | View |
|---|
| Enrolled | 2026-05-31 | HTML/Text | Link | View |
| Engrossed | 2026-04-14 | HTML/Text | Link | View |
| Introduced | 2025-11-14 | HTML/Text | Link | View |
Amendments
Supplemental Documents
| Title | Description | Date | Format | Source | View |
|---|
| No supplemental documents for Illinois HB4203 currently on file. |
